Physician profile
Yoko Bean
NPI 1366822025
$8,812.72
in general payments reported to CMS, 2019-2025
18 companies · $2,139 in 2025
The $2,139 reported for 2025 was more than what 84% of Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) providers received nationally (typical 2025 total: $413).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $708 · 2020: $959 · 2021: $280 · 2022: $1,125 · 2023: $1,464 · 2024: $2,138 · 2025: $2,139.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,174 · Travel and Lodging: $566.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,174.39 |
| Travel and Lodging | $565.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coloplast Corp | $2,865.16 | 2019-2025 | Saffron |
| Medtronic, INC. | $1,733.79 | 2022-2025 | Interstim, Altaviva |
| Axonics, INC. | $1,477.85 | 2021-2023 | Axonics |
| Bluewind Medical | $838.78 | 2024-2025 | Revi |
| Boston Scientific Corporation | $606.19 | 2019-2025 | Capio Rp, Bulkamid, Upsylon |
| Abbvie INC. | $354.39 | 2022-2025 | Botox |
| Astellas Pharma US INC | $283.83 | 2020-2023 | Myrbetriq |
| Medtronic USA, INC. | $281.26 | 2019 | |
| Sumitomo Pharma America, INC. | $80.09 | 2023-2025 | Gemtesa |
| 180 Medical, INC. | $50.07 | 2022-2024 | |
| Applied Medical Resources Corporation | $45.36 | 2025 | |
| Urovant Sciences INC | $42.43 | 2022 | |
| Intuitive Surgical, INC. | $31.17 | 2024 | |
| C. R. Bard, INC. & Subsidiaries | $30.89 | 2022 | |
| Valencia Technologies Corporation | $28.70 | 2022 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $24.22 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $22.71 | 2022 | |
| Allergan, INC. | $15.83 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Yoko Bean listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.